Whey Protein and Adaptogenic Supplementation in Physically Active Males
Whey Protein and Adaptogenic Herb Supplementation in Physically Active Males: A Randomised Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether whey protein, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active males. The adaptogenic blend contains 600mg ashwagandha root extract.The main questions the study aims to answer are: Does whey protein improve muscle strength and recovery in physically active males? Does adding ashwagandha to whey protein further improve stress, recovery, sleep, and wellbeing compared with protein alone? Are there differences between whey protein when combined with the adaptogenic blend? Researchers will compare two supplement groups:
- Whey protein
- Whey protein with ashwagandha Participants will:
- Take their assigned supplement for 6 weeks
- Attend two testing sessions before and after the intervention
- Complete questionnaires about recovery, sleep, stress, soreness, and digestive health
- Provide saliva samples to measure stress, hormone, immune, and inflammation markers
- Complete muscle strength tests, including handgrip strength and push-up testing
- Complete a 24-hour dietary recall
- The study includes physically active males aged 18 to 45 years who regularly participate in structured training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2026
CompletedStudy Start
First participant enrolled
July 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
July 22, 2026
July 1, 2026
2 months
July 16, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Salivary Cortisol Concentration
Change in salivary cortisol concentration from baseline to post-intervention following 6 weeks of whey protein supplementation with or without an adaptogenic herb blend containing ashwagandha KSM-66®. Results will be reported in ng/mL.
Time Frame: Baseline and Week 6
Secondary Outcomes (8)
Handgrip Strength
Time Frame: Baseline and Week 6
Upper Body Muscular Endurance
Time Frame: Baseline and Week 6
Perceived Recovery and Wellbeing
Time Frame: Baseline and Week 6
Salivary DHEA-S Concentration
Time Frame: Baseline and Week 6
Dietary Intake
Time Frame: Baseline and Week 6
- +3 more secondary outcomes
Study Arms (2)
Whey protein
ACTIVE COMPARATORParticipants will consume a whey protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.
Whey Protein + Adaptogenic Blend
EXPERIMENTALParticipants will consume a whey protein supplement containing ashwagandha KSM-66® (600 mg) for 6 weeks. Assessments will be conducted at baseline and post-intervention.
Interventions
Participants will consume a whey protein supplement for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (600 mg) for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.
Eligibility Criteria
You may qualify if:
- Male, aged 18-45 years
- Currently participating in regular structured athletic or physical training (≥3 sessions per week)
- Free from musculoskeletal injury that would prevent testing
- Willing to maintain usual diet and training habits during the study
- Not currently using protein supplements or adaptogenic supplements
- Signing of informed consent form
You may not qualify if:
- Known allergy or sensitivity to dairy, ashwagandha or nightshades
- Current use of prescribed medication that may interact with the supplements
- Thyroid disorders, autoimmune conditions, hormone-sensitive conditions, or other medical conditions
- Diagnosed eating disorder or condition affecting protein metabolism
- Current musculoskeletal injury preventing participation in testing
- Current use of other protein supplements or adaptogens
- No signing of informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Strength and Nutrition Ltd
Brighton, East Sussex, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Olivia C Coope, PhD(c)
Sports Performance and Applied Research in Trials and Analysis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants and outcome assessors will be blinded to group allocation. Supplements will be provided in identical blank tubs to minimise identification of the assigned intervention. Group allocation codes will be concealed until completion of data collection and primary analyses.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD(c)
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 21, 2026
Study Start
July 20, 2026
Primary Completion (Estimated)
September 20, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. Data collected in this study will be anonymised and retained only for the duration of analysis before permanent deletion, in accordance with the study protocol, participant consent, and UK GDPR requirements.